title: Nebulized liposomal amphotericin B for treating Aspergillus empyema with bronchopleural fistula.
authors.affiliation: 1 Toranomon Hospital Tokyo, Japan and.
authors.forename: Shigeo
authors.initials: S
authors.lastname: Hanada
authors.forename: Hironori
authors.initials: H
authors.lastname: Uruga
authors.forename: Hisashi
authors.initials: H
authors.lastname: Takaya
authors.forename: Atsushi
authors.initials: A
authors.lastname: Miyamoto
authors.forename: Nasa
authors.initials: N
authors.lastname: Morokawa
authors.forename: Atsuko
authors.initials: A
authors.lastname: Kurosaki
authors.forename: Kazuma
authors.initials: K
authors.lastname: Kishi
mesh_terms: D000280:Administration, Inhalation; D000666:Amphotericin B / Q000008:administration & dosage* / Q000627:therapeutic use; D000935:Antifungal Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D001232:Aspergillus fumigatus / Q000302:isolation & purification*; D001983:Bronchial Fistula / Q000382:microbiology*; D004653:Empyema / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010995:Pleural Diseases / Q000382:microbiology*; D055732:Pulmonary Aspergillosis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*
chemical_list: D000935:Antifungal Agents; C068538:liposomal amphotericin B; D000666:Amphotericin B